mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |